Probiotic Biotherapy: Discussing its Influential Role in Oral Health

Introduction: Probiotics are widely known for their health promoting benefits, especially with its association to gastrointestinal health. For many years, most research has been focused on the prevention or treatment of gastrointestinal infections or diseases. However, recently probiotics has been a subject of investigation with its association to oral health. This review of literature is designed to analyze the effectiveness of using probiotics as a preventative and therapeutic method for oral infections/diseases such as periodontitis, dental caries, and the like. Methods: Databases such as the PubMed, and Google Scholar were utilized to find current and relevant findings for this reviewed literature. Mendeley was utilized to gather and store findings. Following keyword search items include probiotics, oral health, periodontal diseases, periodontitis, dental caries, gingivitis, halitosis, Lactobacilli, and biotherapy. Articles were narrowed down to include studies published within the last 5 years. Results: Short-term clinical studies suggest that the oral intake of probiotics show a strong inhibitory effect on the growth and biofilm formation of pathogenic strains, stimulate the immune function, and regulate the inflammatory response. Their repeated success in inhibiting harmful oral bacteria suggests that the use of probiotics holds a promising future in dentistry. Conclusion: Although still in its initial stages, the use of probiotics is being established as a living biotherapeutic designed to restore normal oral microflora in the oral cavity. More long-term clinical trials are needed to fully understand their functioning and substantiate their role in oral health.https://scholarscompass.vcu.edu/denh_student/1023/thumbnail.jp

Mechanism of action of probiotics

The modern diet doesn't provide the required amount of beneficial bacteria. Maintenance of a proper microbial ecology in the host is the main criteria to be met for a healthy growth. Probiotics are one such alternative that are supplemented to the host where by and large species of Lactobacillus, Bifidobacterium and Saccharomyces are considered as main probiotics. The field of probiotics has made stupendous strides though there is no major break through in the identification of their mechanism of action. They exert their activity primarily by strengthening the intestinal barrier and immunomodulation. The main objective of the study was to provide a deep insight into the effect of probiotics against the diseases, their applications and proposed mechanism of action

Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness.

Purpose of reviewLoss of 'health-promoting' microbes and overgrowth of pathogenic bacteria (dysbiosis) in ICU is believed to contribute to nosocomial infections, sepsis, and organ failure (multiple organ dysfunction syndrome). This review discusses new understanding of ICU dysbiosis, new data for probiotics and fecal transplantation in ICU, and new data characterizing the ICU microbiome.Recent findingsICU dysbiosis results from many factors, including ubiquitous antibiotic use and overuse. Despite advances in antibiotic therapy, infections and mortality from often multidrug-resistant organisms (i.e., Clostridium difficile) are increasing. This raises the question of whether restoration of a healthy microbiome via probiotics or other 'dysbiosis therapies' would be an optimal alternative, or parallel treatment option, to antibiotics. Recent clinical data demonstrate probiotics can reduce ICU infections and probiotics or fecal microbial transplant (FMT) can treat Clostridium difficile. This contributes to recommendations that probiotics should be considered to prevent infection in ICU. Unfortunately, significant clinical variability limits the strength of current recommendations and further large clinical trials of probiotics and FMT are needed. Before larger trials of 'dysbiosis therapy' can be thoughtfully undertaken, further characterization of ICU dysbiosis is needed. To addressing this, we conducted an initial analysis demonstrating a rapid and marked change from a 'healthy' microbiome to an often pathogen-dominant microbiota (dysbiosis) in a broad ICU population.SummaryA growing body of evidence suggests critical illness and ubiquitous antibiotic use leads to ICU dysbiosis that is associated with increased ICU infection, sepsis, and multiple organ dysfunction syndrome. Probiotics and FMT show promise as ICU therapies for infection. We hope future-targeted therapies using microbiome signatures can be developed to correct 'illness-promoting' dysbiosis to restore a healthy microbiome post-ICU to improve patient outcomes

Use of water soluble extracts from ulva sp. by probiotics and fish bacterial pathogens

BACKGROUNDS The potential of seaweeds as dietary components is considered for a wide range of cultured fish species. In this context, Ulva is investigated as a good source of protein, minerals and vitamins. In addition, of probiotics are used to improve fish growth and modulate immune system and intestinal microbiota. To promote probiotics colonization and maintenance in the intestine, prebiotics are included in fish diets. Prebiotics are indigestible substrates used as energy sources for gastrointestinal microbiota, with a positive effect on the nutrition and health status of the host. In the present work, ability of selected probiotic and fish pathogen strains to use water soluble extracts from Ulva as nutrient source has been evaluated. MATERIALS AND METHODS Water-soluble extracts from Ulva sp. prepared by sonication of dehydrated samples were used to supplement minimum medium (M9). Probiotics and pathogens growth was evaluated based on the optical densities measured with a microplate reader. RESULTS AND CONCLUSIONS Probiotics were able to grow in minimum medium using water soluble extracts as nutrient source. On the other hand, P. damselae subsp. piscicida and V. harveyistrains were also able to grow with Ulvaextracts as nutrient source. However, incubation time to reach maximum growth was longer. Although Ulva extract may support growth of both probiotics and pathogen bacteria, faster growth of probiotics may help for the establishment of probiotic populations in the intestinal environment. In addition, beneficial effects on growth performance, gut microbiota, immunity and disease resistance of Ulva for Solea senegalensisare being studied. This work was funded by INIA, Ministerio de Economía y Competitividad and FEDER (RTA201400023 C0202).This work was funded by INIA, Ministerio de Economía y Competitividad and FEDER (RTA201400023 C0202).Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech

Pengaruh Suplementasi Seng Dan Probiotik Pasca Perawatan Diare Akut Cair Anak Terhadap Kejadian Diare Berulang

Background. Diarrhea remains a major health problem among children under five years old in developing countries due to its high morbidity. Prevention of diarrhea is needed to reduce the high incidence. Zinc has a function to shorten duration of diarrhea and the use of probiotics preventing and treat acute diarrhea. Objective. To prove effect of zinc and probiotic suplementation on the incidence of recurrent acute watery diarrhea in children aged 6-24 months post-hospitalization. Method. Seventy five subjects aged 6-24 months with acute diarrhea in Dr. Kariadi Hospital, the subject of study I, was observed. The subjects were randomly divided into four groups and received treatment in the form of zinc supplementation, supplementation with probiotics, or a combination of zinc and probiotics and one group as control. Each group received the standard form of rehydration therapy and dietetic. Survival analysis was used to analyze the incidence of recurrent diarrhea and Kruskal wallis was used to analyze the difference of frequency and duration of recurrent diarrhea between four groups. Result. The group who received zinc in conjunction with probiotics had mean recurrent of diarrhea longer than the other three groups (10.94 weeks 95% CI 9.24 - 12.65). There was no statistically significant difference in the mean survival of diarrhea in the four groups (p = 0.892). No significant differences in frequency and duration of recurrent diarrhea in four groups at first, second and third month postsupplementation. Conclussion. There were no significant differences between groups of zinc, probiotics and a combination of zinc and probiotics on the average recurrent diarrhea, duration and frequency of diarrhea. Keyword : acute watery diarrhea, recurrent diarrhea, zinc, probiotic

Emerging trends in 'smart probiotics' : functional consideration for the development of novel health and industrial applications

The link between gut microbiota and human health is well-recognized and described. This ultimate impact on the host has contributed to explain the mutual dependence between humans and their gut bacteria. Gut microbiota can be manipulated through passive or active strategies. The former includes diet, lifestyle, and environment, while the latter comprise antibiotics, pre- and probiotics. Historically, conventional probiotic strategies included a phylogenetically limited diversity of bacteria and some yeast strains. However, biotherapeutic strategies evolved in the last years with the advent of fecal microbiota transplant (FMT), successfully applied for treating CDI, IBD, and other diseases. Despite the positive outcomes, long-term effects resulting from the uncharacterized nature of FMT are not sufficiently studied. Thus, developing strategies to simulate the FMT, using characterized gut colonizers with identified phylogenetic diversity, may be a promising alternative. As the definition of probiotics states that the microorganism should have beneficial effects on the host, several bacterial species with proven efficacy have been considered next generation probiotics. Non-conventional candidate strains include Akkermansia muciniphila, Faecalibacterium prausnitzii, Bacteroides fragilis, and members of the Clostridia clusters IV, XIVa, and XVIII. However, viable intestinal delivery is one of the current challenges, due to their stringent survival conditions. In this review, we will cover current perspectives on the development and assessment of next generation probiotics and the approaches that industry and stakeholders must consider for a successful outcome

A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells.

Background: Inflammatory Bowel Diseases (IBD), are considered a growing global disease, with about ten million people being affected worldwide. Maintenance of intestinal barrier integrity is crucial for preventing IBD onset and exacerbations. Some recent patents regarding oily formulations containing probiotics (WO2010122107A1 and WO2010103374A9) and the use of probiotics for gastrointestinal complaints (US20110110905A1 and US9057112B2) exist, or are pending application. Objective: In this work, we studied the effect of a fixed combination of registered Lactobacillus reuteri and Lactobacillus acidophilus strains and herbal extracts in an in vitro inflammation experimental model. Methods: Caco-2 cell monolayer was exposed to INF-\u3b3+TNF-\u3b1 or to LPS; Trans Epithelial Electrical Resistance (TEER) and paracellular permeability were investigated. ZO-1 and occludin Tight Junctions (TJs) were also investigated by mean of immunofluorescence. Results: Pre-treatment with the fixed combination of probiotics and herbal extracts prevented the inflammation-induced TEER decrease, paracellular permeability increase and TJs translocation. Conclusions: In summary, the fixed combination of probiotics and herbal extracts investigated in this research was found to be an interesting candidate for targeting the re-establishment of intestinal barrier function in IBD conditions

Helicobacter pylori infection and gastric dysbiosis: Can probiotics administration be useful to treat this condition?

Helicobacter pylori (Hp) is responsible for one of the most common infections in the world. 'e prevalence exceeds 50% of the population in developing countries, and approximately one-third of the adults are colonized in North Europe and North America. It is considered a major pathogenic agent of chronic gastritis, peptic ulcer, atrophic gastritis, gastric cancer, and mucosa-associated lymphoid tissue lymphoma (MALT). Hp colonization modifies the composition of gastric microbiota that could drive the development of gastric disorders. Currently, an emerging problem in Hp treatment is represented by the increasing rate of antimicrobial therapy resistance. In this context, the search for adjuvant agents can be very useful to overcome this issue and probiotics administration can represent a valid option. The aim of this review is to describe the gastric microbiota changes during Hp colonization, the mechanisms of action, and a possible role of probiotics in the treatment of this infection

Health benefits and health claims of probiotics: bridging science and marketing

Health claims for probiotics are evaluated by the Panel on Dietetic Products, Nutrition and Allergies of the European Food Safety Authority. Despite a substantial amount of basic and clinical research on the beneficial effects of probiotics, all of the evaluated claim applications thus far have received a negative opinion. With the restrictions on the use of clinical endpoints, validated biomarkers for gut health and immune health in relation to reduction in disease risk are needed. Clear-cut criteria for design as well as evaluation of future studies are needed. An open dialogue between basic and clinical scientists, regulatory authorities, food and nutrition industry, and consumers could bridge the gap between science and marketing of probiotic